Dapagliflozin as dapagliflozin propanediol, metformin (Xigduo Xr)
Dapagliflozin as dapagliflozin propanediol, metformin
Astrazeneca Pharmaceuticals (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Astrazeneca Pharmaceuticals (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Xigduo xr 10 mg/ 500 MG EACH TABLET CONTAINS: DAPAGLIFLOZIN AS DAPAGLIFLOZIN PROPANEDIOL 10,0 mg METFORMIN HCL 500,0 mg | 10 mg/ 500 mg | 52041252/21.2/0412 | Cancelled | Not determined | None |
| Xigduo xr 10 mg/ 1000 MG EACH TABLET CONTAINS: DAPAGLIFLOZIN AS DAPAGLIFLOZIN PROPANEDIOL 10,0 mg METFORMIN HCL 1000,0 mg | 10 mg/ 1000 mg | 52041352/21.2/0413 | Cancelled | Not determined | None |
| Xigduo xr 5 mg/ 500 MG EACH TABLET CONTAINS: DAPAGLIFLOZIN AS DAPAGLIFLOZIN PROPANEDIOL 5,0 mg METFORMIN HCL 500,0 mg | 5 mg/ 500 mg | 52041452/21.2/0414 | Cancelled | Not determined | None |
| Xigduo xr 5 mg/ 1000 MG EACH TABLET CONTAINS: DAPAGLIFLOZIN AS DAPAGLIFLOZIN PROPANEDIOL 5,0 mg METFORMIN HCL 1000,0 mg | 5 mg/ 1000 mg | 52041552/21.2/0415 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.